story of the week
Ponesimod vs Teriflunomide in Relapsing MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial
JAMA Neurol 2021 May 01;78(5)558-567, L Kappos, RJ Fox, M Burcklen, MS Freedman, EK Havrdová, B Hennessy, R Hohlfeld, F Lublin, X Montalban, C Pozzilli, T Scherz, D D'Ambrosio, P Linscheid, A Vaclavkova, M Pirozek-Lawniczek, H Kracker, T SprengerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.